Inventor · Village of La Jolla, CA, US

John C. Timmer

41Patents
6h-index
27Co-inventors
65Inventor score

Filing activity: Jun 28, 2012 → May 8, 2024

Most-cited inventions

PatentTitleAreaCited byStatus
US9045541B2 CD47 antibodies and methods of use thereof Chemistry; Metallurgy 58 Active
US9663575B2 CD47 antibodies and methods of use thereof Chemistry; Metallurgy 19 Active
US8980266B2 Serpin fusion polypeptides and methods of use thereof Chemistry; Metallurgy 14 Active
US9914765B2 WAP domain fusion polypeptides and methods of use thereof Chemistry; Metallurgy 9 Active
US8986688B2 WAP domain fusion polypeptides and methods of use thereof Chemistry; Metallurgy 8 Active
US9920109B2 Serpin fusion polypeptides and methods of purification thereof Chemistry; Metallurgy 6 Active
US11866507B2 Multispecific polypeptide constructs having constrained CD3 binding and methods of using the same Chemistry; Metallurgy 5 Active
US10723785B2 Serpin fusion polypeptides and methods of use thereof Chemistry; Metallurgy 5 Active
US10093742B2 Multispecific GITR-binding fusion proteins and methods of use thereof Chemistry; Metallurgy 4 Active
US10730929B2 Serpin fusion polypeptides and methods of use thereof Chemistry; Metallurgy 3 Active
US11046752B2 Serpin fusion polypeptides and methods of use thereof Chemistry; Metallurgy 2 Active
US10400029B2 Serpin fusion polypeptides and methods of use thereof Chemistry; Metallurgy 2 Active
US10501551B2 Multivalent and multispecific 41BB-binding fusion proteins Chemistry; Metallurgy 2 Active
US11117972B2 Multivalent and multispecific OX40-binding fusion proteins Chemistry; Metallurgy 2 Active
US10308720B2 Multivalent and multispecific DR5-binding fusion proteins Chemistry; Metallurgy 1 Active
US12043667B2 CLEC12a binding polypeptides and uses thereof Chemistry; Metallurgy 1 Active
US12331132B2 Multispecific polypeptide constructs having constrained CD3 binding and related methods and uses Chemistry; Metallurgy 0 Active
US12297271B2 PD-1 single domain antibodies and therapeutic compositions thereof Chemistry; Metallurgy 0 Active
US10526397B2 Non-immunogenic single domain antibodies Chemistry; Metallurgy 0 Active
US11945869B2 PD-1 single domain antibodies and therapeutic compositions thereof Chemistry; Metallurgy 0 Active
US11208485B2 PD-1 single domain antibodies and therapeutic compositions thereof Chemistry; Metallurgy 0 Active
US12421315B2 CLL-1 targeted immunotherapies Chemistry; Metallurgy 0 Active
US11827691B2 Serpin fusion polypeptides and methods of use thereof Chemistry; Metallurgy 0 Active
US12365728B2 DLL3 single domain antibodies and therapeutic compositions thereof Chemistry; Metallurgy 0 Active
US12227584B2 Multivalent and multispecific OX40-binding fusion proteins Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.